Cerebral toxoplasmosis in HIV-infected patients: a review.
Dian S, Ganiem AR, Ekawardhani S.
Pathog Glob Health. 2023 Feb;117(1):14-23. doi: 10.1080/20477724.2022.2083977. Epub 2022 Jun 11.
Advances and Challenges in Understanding Cerebral Toxoplasmosis.
Schlüter D, Barragan A.
Front Immunol. 2019 Feb 14;10:242. doi: 10.3389/fimmu.2019.00242. eCollection 2019.
HIV-Related Cerebral Toxoplasmosis Revisited: Current Concepts and Controversies of an Old Disease.
Vidal JE.
J Int Assoc Provid AIDS Care. 2019 Jan-Dec;18:2325958219867315. doi: 10.1177/2325958219867315.
Toxoplasma gondii-induced neuronal alterations.
Parlog A, Schlüter D, Dunay IR.
Parasite Immunol. 2015 Mar;37(3):159-70. doi: 10.1111/pim.12157.
Central nervous system infection with Toxoplasma gondii.
Marra CM.
Handb Clin Neurol. 2018;152:117-122. doi: 10.1016/B978-0-444-63849-6.00009-8.
Toxoplasma gondii and the blood-brain barrier.
Feustel SM, Meissner M, Liesenfeld O.
Virulence. 2012 Mar-Apr;3(2):182-92. doi: 10.4161/viru.19004. Epub 2012 Mar 1.
Toxoplasmosis and Neuropsychological Effects.
Inceboz M, Inceboz T.
Turkiye Parazitol Derg. 2021 Mar 2;45(1):49-55. doi: 10.4274/tpd.galenos.2020.6973.
Toxoplasma gondii meningoencephalitis without cerebral MRI findings in a patient with ulcerative colitis under immunosuppressive treatment.
Assimakopoulos SF, Stamouli V, Dimitropoulou D, Spiliopoulou A, Panos G, Anastassiou ED, Marangos M, Spiliopoulou I.
Infection. 2015 Oct;43(5):589-93. doi: 10.1007/s15010-015-0730-9. Epub 2015 Jan 27.
Toxoplasma meningoencephalitis in HIV-seronegative patients: clinical patterns, imaging features and treatment outcome.
Pradhan S, Yadav R, Mishra VN.
Trans R Soc Trop Med Hyg. 2007 Jan;101(1):25-33. doi: 10.1016/j.trstmh.2006.02.021. Epub 2006 Sep 28.
Toxoplasma gondii infection and cerebral toxoplasmosis in HIV-infected patients.
Pereira-Chioccola VL, Vidal JE, Su C.
Future Microbiol. 2009 Dec;4(10):1363-79. doi: 10.2217/fmb.09.89.
